4th Edition of World Congress on Infectious Diseases
June 21-22, 2023 | Rome, Italy
Research on Medicine and Vaccine for Covid-19
COVID-19 has claimed the lives of about 18 million people. Researchers are working around the clock to better understand, cure, and finally eradicate COVID-19 and the sickness that comes with it. WHO and its partners are dedicated to developing COVID-19 vaccines as quickly as possible while maintaining the highest safety requirements. Vaccines go through several stages of research and testing - clinical trials typically have three phases, the last of which is aimed to examine the product's capacity to protect against disease, known as effectiveness. Each phase evaluates the level of risk. Vaccines have previously been developed through a sequence of steps that can take years to complete. Given the critical need for COVID-19 vaccines, enormous financial investments and scientific collaborations are now transforming vaccine development.
- Antivirals
- Vaccines
- Clinical Trials
Ranjan Ramasamy
IDFISH Technology, United States
Stephen Hsu
Augusta University, United States
Hector Javier Gallardo Valencia
Michoacana University, Mexico
Walter Fabricio Silva Martins
LSTM, United Kingdom
Susan M Dallabrida
SPRIM US LLC, United States
Pietro Salvatori
Private Practice, Italy
Hertel Quentin
University of Montpellier, FranceSubmit your abstract Today
Title : Novel nasal formulations containing EC16 to combat long COVID
Stephen Hsu, Augusta University, United States
Title : Selection underlying evolution and spread of SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Concept elicitation, cognitive debriefing and usability testing of COVID symptoms diary
Susan M Dallabrida, SPRIM US LLC, United States
Title : Insecticide resistance and use of household insecticides for personal protection: Insights from vector-borne disease outbreaks
Walter Fabricio Silva Martins, LSTM, United Kingdom
Title : Evaluating the effectiveness of antimicrobial stewardship on escherichia coli resistance in patients with urinary tract infection
Paulo Arroyo, Warwick Medical School, United Kingdom
Title : iiCON: Developing the infectious disease innovation ecosystem
Becky Jones-Phillips, Liverpool School of Tropical Medicine, United Kingdom